Department of Epidemiology, Biostatistics and Occupational Health (Brunetti, Ayele, Filion), McGill University; Centre for Clinical Epidemiology (Brunetti, Ayele, Yu, Ernst, Filion), Lady Davis Institute for Medical Research, and Divisions of Endocrinology (Yu) and Pulmonary Medicine (Ernst), Jewish General Hospital, McGill University; Department of Medicine (Ernst, Filion), McGill University, Montréal, Que.
CMAJ Open. 2021 Jan 25;9(1):E62-E70. doi: 10.9778/cmajo.20200013. Print 2021 Jan-Mar.
People with type 2 diabetes are at greater risk for infections than those without type 2 diabetes. Our objective was to examine the association between type 2 diabetes and the risk of community-acquired pneumonia (CAP).
In this systematic review and meta-analysis, we searched MEDLINE, Embase, CINAHL, ProQuest theses and dissertations, Global Health, the Global Index Medicus of the World Health Organization, and Google Scholar. We included observational studies published in English or French between Jan. 1, 1946 (start of MEDLINE) and July 18, 2020. Two independent reviewers extracted data and assessed quality using the ROBINS-I tool. DerSimonian-Laird random-effects models were used to pool estimates of the association between type 2 diabetes and CAP.
Our systematic review included 15 articles, reporting on 13 cohort studies and 4 case-control studies (14 538 968 patients). All studies reported an increased risk of pneumonia among patients with type 2 diabetes, and all were at serious risk of bias. When estimates were pooled across studies, the pooled relative risk was 1.64 (95% confidence interval [CI] 1.55-1.73); although there was a substantial amount of relative heterogeneity ( 94.2), the amount of absolute heterogeneity was more modest (T 0.008). The relative risk was 1.70 (95% CI 1.63-1.77, 85.2%, T 0.002) among cohort studies ( = 13), and the odds ratio was 1.54 (95% CI 1.14-2.09, 92.7%, T 0.07) among case-control studies ( = 4).
Type 2 diabetes may be associated with an increased risk of CAP; however, the available evidence is from studies at serious risk of bias, and additional, high-quality studies are needed to confirm these findings.
CRD42018116409.
相较于非 2 型糖尿病患者,2 型糖尿病患者更易发生感染。本研究旨在探究 2 型糖尿病与社区获得性肺炎(CAP)风险之间的关系。
本系统评价和荟萃分析检索了 MEDLINE、Embase、CINAHL、ProQuest 论文和学位论文、全球健康数据库、世界卫生组织全球索引医学期刊和 Google Scholar,纳入了 1946 年 1 月 1 日(MEDLINE 起始日期)至 2020 年 7 月 18 日期间发表的英语或法语观察性研究。两位独立审查员使用 ROBINS-I 工具提取数据并评估质量。采用 DerSimonian-Laird 随机效应模型汇总 2 型糖尿病与 CAP 之间关联的估计值。
本系统评价共纳入 15 项研究,涉及 13 项队列研究和 4 项病例对照研究(共纳入 14538968 例患者)。所有研究均报道 2 型糖尿病患者发生肺炎的风险增加,且所有研究均存在严重偏倚风险。对研究进行汇总后,合并相对风险为 1.64(95%置信区间[CI]1.55-1.73);虽然存在较大的相对异质性( I 2 94.2%),但绝对异质性程度较小( T 0.008)。在队列研究( n 13)中,相对风险为 1.70(95%CI1.63-1.77, I 2 85.2%, T 0.002),在病例对照研究( n 4)中,比值比为 1.54(95%CI1.14-2.09, I 2 92.7%, T 0.07)。
2 型糖尿病可能与 CAP 风险增加相关;但现有证据来自偏倚风险严重的研究,需要进一步开展高质量研究来证实上述发现。
PROSPERO 注册号:CRD42018116409。